EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2025.

特に断りのない限り、数値はすべて千単位でCAD表示。

• Reported revenue for Q2 2025 of $3,689, an increase of $3,026 relative to the comparable period in the prior year. The increase was primarily related to a large-scale machine sale and the commissioning of two small-scale machines.
• Reported royalty revenues for Q2 2025 of $474, an increase of $60 relative to the comparable period in the prior year. Royalties grew due to increased royalty partners, product sales, and partner production for the quarter.
• Gross margin for the three months ending Q2 2025 was 33% compared to (25)% for the three months ending Q2 2024. The increase in margin was a result of higher machine sales, royalties, and tolling revenue for the quarter.
• Reported an increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $10 for Q2 2025 relative to the comparable period in the prior year, with the increase primarily related to recruitment fees.
• Reported Adjusted EBITDA⁽¹⁾ income for Q2 2025 of $112, an increase of $1,380 from the comparable period in the prior year.

連結業績：

Note: (1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Six Months Ended March 31, 2025 (expressed in 000’s)

• Reported revenue of $4,866, an increase of $2,941 relative to the comparable period in the prior year. The increase was primarily related to additional machine sales. 
• Reported Royalty revenues of $1,033, an increase of $139 or 16% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
• Reported an increase in SG&A costs of $14 for the six months ending March 31, 2025, relative to the comparable period in the prior year, with the increase primarily related to tradeshow attendance and recruitment fees offset by reduced legal costs associated with the capitalization of the Term Loan and Credit facility issuance costs.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $523 for the six months ended March 31, 2025, an increase of $1,501 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q2 2025 and Subsequently:

• Signed a Technology Evaluation and License Option Agreement with Solve Solutions LTDA of Brazil.
• Signed a License Agreement Amendment with BranchOut Food Inc. for the exclusive rights to produce dried blueberry products using EnWave’s REV^TM technology in Peru.
• Signed a License Agreement Amendment with Patatas Fritas Torres S.L. of Spain to expand the product portfolio to focus on commercializing healthy, protein-rich snack products.
• Signed an Equipment Purchase Agreement and License Amendment with Sprouted Proteins for a 10kW REV™ machine and the grant of exclusive rights to produce certain starch-based snack products.
• Signed an Equipment Purchase Agreement and Commercial Licence Agreement with Hokkai Yamato Foods for a 10kW REV^TM  machine.
• Signed a Master Service Agreement and First Work Order with Bio Technique LLC to evaluate EnWave’s REV^TM dehydration technology.
• Signed an Equipment Purchase Agreement and Licence Agreement Amendment with MicroDried® for a 60kW REV™ machine and the exclusive rights to use REV^TM technology for apple ingredient production in Washington, Oregon, and Idaho.
• Received the Second Progress Payment related to the Equipment Purchase Agreement with Procescir S.A. de C.V. of Mexico for 120kW Radiant Energy Vacuum Machinery.
• Signed a License Agreement Amendment with Creations Foods US Inc. for an additional right to produce dried cheese snacks for pet treat applications on a non-exclusive basis in the United States. 
• The Company recognized a $836 USD tax refund for NutraDried during the quarter in discontinued operations.  The tax refund was for the Employee Retention Tax Credit which is a refundable tax credit from the United States government for businesses that were affected during the COVID-19 pandemic.  The Company does not expect to receive any additional tax refunds or credits related to NutraDried.
• The Company appointed its first international Business Development Manager, based in the Netherlands. This new Business Development Manager will play a pivotal role in strengthening the Company’s international presence and accelerating growth in the European market.
• Subsequent to the quarter, the Company repurchased a 10 kW REV™ machine and 120kW REV™ machine from an Illinois, U.S. based cannabis company. The transaction increases inventory levels and strengthens the Company’s position to deliver on partnership opportunities, expediting the fulfillment and revenue recognition of prospective REV™ machine sales.  

非IFRS財務指標：

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring income and expenses, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management.  Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca

エンウェーブについて

EnWave社は、真空マイクロ波脱水の革新と応用の世界的リーダーです。EnWave社は、BC州デルタに本社を置き、強固な知的財産ポートフォリオを開発し、放射エネルギー真空(REV™)技術を完成させ、革新的なアイデアを、食品、製薬、大麻産業用の、実績のある、一貫した、拡張可能な乾燥ソリューションに変えました。

With more than fifty royalty-generating partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

エンウェーブの戦略は、凍結乾燥、ラック乾燥、風乾よりも、より良く、より速く、より経済的に乾燥させ、エキサイティングな新製品を生産し、最適な水分レベルに最大7倍速く到達し、製品の味、食感、色、栄養価を向上させるという次のようなメリットを享受したいと考える食品製造業者と、ロイヤリティを伴う商業ライセンスを締結することである。

詳しくはEnWave.netをご覧ください。

エンウェーブ・コーポレーション

ブレント・チャールトン CFA

社長兼CEO

詳細はこちら：

ブレント・チャールトン、CFA、社長兼CEO、電話：+1 (778) 378-9616
E-mail:bcharleton@enwave.net      

ディラン・マレイ、CPA、CFO、電話：+1 (778) 870-0729
E-mail:dmurray@enwave.net  

将来予測情報に関する記述のセーフハーバー：本プレスリリースには、経営陣の期待、見積もり、予測に基づく将来の見通しに関する情報が含まれている場合があります。当社の成長戦略、製品開発、市場での地位、予想される支出、クロージング後に期待されるシナジー効果に関する記述を含め、将来に対する期待や予測に言及する記述はすべて、将来の見通しに関する記述です。本リリースで言及されている第三者の主張はすべて、その正確性を保証するものではありません。本リリースに記載されている市場情報に関する第三者による言及は、当社が独自に一次調査を行ったものではないため、その正確性を保証するものではありません。これらの記述は将来の業績を保証するものではなく、多くのリスク、不確実性および仮定を含んでいます。当社は、実際の結果と大きく異なる可能性のある重要な要因を特定するよう努めましたが、予想、見積りまたは意図したとおりの結果とならないその他の要因が存在する可能性があります。実際の結果や将来の事象は、かかる記述で予想されたものとは大きく異なる可能性があるため、かかる記述が正確であることを保証するものではありません。したがって、読者は将来の見通しに関する記述を過度に信頼すべきではありません。

TSXベンチャー取引所およびその規制サービスプロバイダー（この用語はTSXベンチャー取引所の方針で定義されています）は、本リリースの妥当性または正確性について責任を負いません。